IDEAYA Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IDYA and other ETFs, options, and stocks.

About IDYA

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. 

CEO
Yujiro S. Hata
CEOYujiro S. Hata
Employees
145
Employees145
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2015
Founded2015
Employees
145
Employees145

IDYA Key Statistics

Market cap
3.83B
Market cap3.83B
Price-Earnings ratio
-20.42
Price-Earnings ratio-20.42
Dividend yield
Dividend yield
Average volume
710.00K
Average volume710.00K
High today
$40.56
High today$40.56
Low today
$39.31
Low today$39.31
Open price
$39.34
Open price$39.34
Volume
833.28K
Volume833.28K
52 Week high
$40.58
52 Week high$40.58
52 Week low
$23.23
52 Week low$23.23

Stock Snapshot

IDEAYA Biosciences(IDYA) stock is priced at $39.67, giving the company a market capitalization of 3.83B. It carries a P/E multiple of -20.42.

As of 2026-08-22, IDEAYA Biosciences(IDYA) stock has fluctuated between $39.31 and $40.56. The current price stands at $39.67, placing the stock +0.9% above today's low and -2.2% off the high.

IDEAYA Biosciences(IDYA) shares are trading with a volume of 833.28K, against a daily average of 710K.

In the last year, IDEAYA Biosciences(IDYA) shares hit a 52-week high of $40.58 and a 52-week low of $23.23.

In the last year, IDEAYA Biosciences(IDYA) shares hit a 52-week high of $40.58 and a 52-week low of $23.23.

IDYA News

Simply Wall St 2d
IDEAYA Biosciences Is Up 5.2% After Genentech KRAS G12D Trial Collaboration News - Has The Bull Case Changed?

IDEAYA Biosciences announced that it entered a clinical collaboration with Genentech to test IDE892, its investigational MTA-cooperative PRMT5 inhibitor, in com...

IDEAYA Biosciences Is Up 5.2% After Genentech KRAS G12D Trial Collaboration News - Has The Bull Case Changed?
CNN 3d
symbol__ Stock Quote Price and Forecast - CNN

...

symbol__ Stock Quote Price and Forecast - CNN
TipRanks 3d
IDEAYA Biosciences: Strategic Oncology Collaborations and Strong Cash Position Support Buy Rating with Unchanged $58 Price Target

In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on IDEAYA Biosciences, with a price target of $58.00. Unlock powerful inve...

Analyst ratings

93%

of 15 ratings
Buy
93.3%
Hold
6.7%
Sell
0%

People also own

Based on the portfolios of people who own IDYA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.